Brief: Summit Therapeutics National Medical Products Administration Of China Approved Ivonescimab In Combination With Chemotherapy
24/05/2024 14:14
May 24 (Reuters) - Summit Therapeutics Inc SMMT.O :
* SUMMIT THERAPEUTICS: NATIONAL MEDICAL PRODUCTS
ADMINISTRATION OF
CHINA APPROVED IVONESCIMAB IN COMBINATION WITH CHEMOTHERAPY
Source text for Eikon: ID:n0001599298-24-000092
Further company coverage: SMMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering